Antibacterial drugs, a subset of antimicrobials, are essential in the medical arsenal against bacterial infections. These drugs act through various mechanisms to inhibit bacterial growth, disrupt essential cellular processes, or outrightly kill the bacteria. Their versatility allows for the treatment of a wide range of bacterial infections, from common respiratory ailments to severe systemic diseases. In recent years, the field of antibacterial drug development has witnessed advancements in research and technology. Scientists are exploring novel targets and innovative approaches to counteract the rising threat of antibiotic resistance. Combination therapies, where multiple drugs are used simultaneously, are being explored as a strategy to enhance efficacy and minimize the development of resistance. The future of antibacterial drugs lies in a multidisciplinary approach, involving not only pharmaceutical research but also global collaboration to address issues of access, affordability, and responsible use. By staying at the forefront of scientific innovation and promoting a holistic approach, the medical community can continue to stay one step ahead of bacterial infections and safeguard public health.
Title : Diagnostic approaches, predictive and prognostic assessments, monitoring, treatment & management of infectious diseases and disease prevention
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The accelerated timeline: Human ecology, climate change, and the next global outbreak
Claudia Ferreira, Sorbonne University, France
Title : Climate change and increasing death due to resistant infection
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Recurrent klebsiella pneumoniae pyogenic liver abscess: Developing a literature-informed 0–2 scoring framework from a solved index case
Martha Grace McLean, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Post-hysterectomy pelvic abscess mimic: An AI-assisted diagnostic stewardship workflow
Setu Shiroya, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Building a clinical reasoning tool from post-transplant MRSA sepsis: A mentored ai workflow
Michaela Mitchell, Anne Burnett Marion School of Medicine at Texas Christian University, United States